Profile data is unavailable for this security.
About the company
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
- Revenue in HKD (TTM)6.46bn
- Net income in HKD1.32bn
- Incorporated2004
- Employees5.60k
- LocationSSY Group LtdRooms 4902-03, 49th Floor, Central Plaza18 Harbour RoadWanchai Hong KongHKG
- Phone+852 26880869
- Fax+852 27873338
- Websitehttp://www.ssygroup.com.hk/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIM Vaccine Co Ltd | 1.28bn | -1.40bn | 9.20bn | 1.62k | -- | 2.34 | -- | 7.19 | -1.16 | -1.16 | 1.06 | 3.24 | -- | -- | -- | 788,462.10 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| InnoCare Pharma Ltd | 796.37m | -680.70m | 9.68bn | 1.09k | -- | 1.13 | -- | 12.16 | -0.4036 | -0.4036 | 0.4719 | 4.37 | 0.073 | 1.39 | 3.39 | 731,289.50 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
| Keymed Biosciences Inc | 381.83m | -387.50m | 10.13bn | 897.00 | -- | 3.14 | -- | 26.52 | -1.49 | -1.49 | 1.45 | 11.51 | 0.0906 | 0.7314 | 26.14 | 425,669.30 | -9.16 | -- | -10.05 | -- | 89.59 | -- | -101.04 | -- | 9.18 | -- | 0.123 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
| Shanghai Henlius Biotech Inc | 5.82bn | 588.78m | 10.24bn | 3.64k | 17.44 | 4.33 | 10.49 | 1.76 | 1.08 | 1.08 | 10.66 | 4.35 | 0.5731 | 1.95 | 9.10 | 1,599,506.00 | 5.80 | -8.59 | 12.47 | -14.14 | 72.64 | 71.77 | 10.12 | -27.37 | 0.3786 | 6.48 | 0.6512 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| Luye Pharma Group Ltd | 6.62bn | 574.32m | 10.27bn | 5.27k | 17.79 | 0.76 | 7.67 | 1.55 | 0.1534 | 0.1534 | 1.78 | 3.59 | 0.247 | 2.42 | 3.60 | 1,256,957.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| SciClone Pharmaceuticals (Holdings) Ltd | 3.40bn | 1.21bn | 11.52bn | 1.05k | 9.86 | 3.14 | 8.43 | 3.39 | 1.86 | 1.86 | 5.23 | 5.83 | 0.7585 | 3.56 | 3.83 | 3,240,705.00 | 26.97 | 27.09 | 33.34 | 36.32 | 74.67 | 76.06 | 35.55 | 35.43 | 4.50 | 33.70 | 0.01 | 22.98 | 14.76 | 17.50 | 31.16 | 15.96 | 25.65 | -- |
| SSY Group Ltd | 6.46bn | 1.32bn | 14.10bn | 5.60k | 10.73 | 2.03 | 8.07 | 2.18 | 0.4427 | 0.4427 | 2.17 | 2.33 | 0.5637 | 3.00 | 3.01 | 1,154,109.00 | 11.59 | 10.51 | 15.58 | 14.03 | 56.01 | 58.72 | 20.57 | 18.62 | 1.60 | 29.61 | 0.317 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
| Simcere Pharmaceutical Group Ltd | 7.13bn | 770.74m | 15.19bn | 7.03k | 20.13 | 1.96 | 13.76 | 2.13 | 0.2891 | 0.2891 | 2.73 | 2.98 | 0.6106 | 3.53 | 2.65 | 1,013,987.00 | 6.60 | 10.17 | 8.94 | 15.60 | 75.43 | 78.82 | 10.80 | 17.50 | 1.87 | 0.9742 | 0.1652 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
| 3SBio Inc | 8.43bn | 1.67bn | 15.39bn | 5.41k | 9.37 | 1.00 | 7.43 | 1.83 | 0.6733 | 0.6733 | 3.45 | 6.31 | 0.3426 | 1.58 | 7.01 | 1,557,573.00 | 6.95 | 7.44 | 9.03 | 9.29 | 84.98 | 82.91 | 20.30 | 21.50 | 2.26 | 22.72 | 0.2266 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
| Zai Lab Ltd | 2.27bn | -2.65bn | 15.56bn | 2.18k | -- | 2.57 | -- | 6.85 | -2.73 | -2.73 | 2.34 | 6.11 | 0.2697 | 2.84 | 5.61 | -- | -31.41 | -37.72 | -36.81 | -42.72 | 62.86 | 64.75 | -116.45 | -282.44 | 4.43 | -- | 0.0596 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
| Grand Pharmaceutical Group Ltd | 10.53bn | 1.88bn | 17.18bn | 10.53k | 9.04 | 1.12 | 7.51 | 1.63 | 0.5356 | 0.5356 | 3.00 | 4.33 | 0.4692 | 2.94 | 10.26 | 999,581.40 | 8.45 | 10.09 | 11.66 | 14.01 | 61.96 | 61.97 | 18.00 | 22.35 | 0.9819 | 22.96 | 0.1831 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
| The United Laboratories Intl. Hldgs Ltd. | 14.82bn | 2.91bn | 17.23bn | 15.00k | 5.91 | 1.25 | 4.89 | 1.16 | 1.60 | 1.60 | 8.15 | 7.56 | 0.6871 | 3.36 | 6.15 | 987,726.30 | 13.51 | 7.89 | 20.52 | 12.64 | 46.11 | 44.17 | 19.66 | 12.73 | 1.74 | -- | 0.1055 | 28.99 | 21.22 | 12.84 | 70.85 | 31.66 | 24.19 | 14.67 |
| WuXi XDC Cayman Inc | 2.29bn | 305.74m | 19.02bn | 1.18k | 56.83 | 3.23 | 51.47 | 8.30 | 0.2794 | 0.2794 | 2.12 | 4.91 | -- | -- | -- | 1,944,112.00 | -- | -- | -- | -- | 26.35 | -- | 13.35 | -- | 4.03 | -- | 0.0005 | -- | 114.44 | -- | 82.07 | -- | -- | -- |
Data as of May 23 2024. Currency figures normalised to SSY Group Ltd's reporting currency: Hong Kong Dollar HKD
15.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management (Hong Kong) Ltd.as of 28 Mar 2024 | 218.06m | 7.35% |
| UBS SDIC Fund Management Co., Ltd.as of 08 Mar 2024 | 61.15m | 2.06% |
| The Vanguard Group, Inc.as of 09 May 2024 | 54.32m | 1.83% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 28.63m | 0.96% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 22.18m | 0.75% |
| BlackRock Fund Advisorsas of 09 May 2024 | 17.07m | 0.58% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 16.01m | 0.54% |
| FIL Investment Management (Singapore) Ltd.as of 31 Jan 2024 | 15.19m | 0.51% |
| Nordea Investment Management AB (Denmark)as of 29 Feb 2024 | 12.42m | 0.42% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 10.47m | 0.35% |
More ▼
Data from 30 Jun 2023 - 16 May 2024Source: FactSet Research Systems Inc.
